Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can arm workouts boost oxygen use in lung disease?

NCT ID NCT05916404

Disease control Sponsor: Gazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether a 6-week program of high-intensity interval training using an arm ergometer can improve oxygen consumption, muscle oxygenation, and physical activity in people with interstitial lung disease. Participants will be randomly assigned to receive the supervised exercise training or usual care. The study measures exercise capacity, muscle oxygen levels, and daily activity to see if arm training offers benefits beyond standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Upper extremity high-intensity interval aerobic exercise training on an arm ergometer
What this could lead to
If effective, this exercise program could become a standard rehabilitation approach to improve exercise capacity and daily activity in people with interstitial lung disease.
What could go wrong
This is a small, early-stage trial, and results may not apply to all patients. Exercise training carries a risk of fatigue or shortness of breath, and benefits may not be sustained long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Jul 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with ILD according to ATS/ERS criteria, * Aged between 18-75 years, * No pulmonary infection during the last month, * Patients who volunteer to participate in the study Exclusion Criteria: Patients with, * Body mass index \>35 kg/m2, * An acute pulmonary exacerbation within the last 4 weeks, have an acute upper or lower respiratory tract infection, * Presence of obstructive pulmonary disease, * Serious neurological, neuromuscular, orthopedic, or other diseases affecting physical functions, * Participated in a planned exercise program within the last three months, * Cognitive impairment that causes them to have difficulty understanding and following exercise test instructions, * Contraindications for exercise testing and/or exercise training according to the American College of Sports Medicine * Cancer, renal or hepatic diseases, * Aortic stenosis, complex arrhythmia, with aortic aneurysm, * Uncontrolled hypertension, diabetes mellitus, heart failure, arrhythmia and serious cardiovascular disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Interstitial lung disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

interstitial lung disease Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Interstitial lung disease

Contacts and locations

Locations

  • Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit

    Ankara, Çankaya, 06490, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.